Microbiota Manipulation With Prebiotics and Probiotics in Patients Undergoing Stem Cell Transplantation

Current Hematologic Malignancy Reports
Tessa M AndermannAmi S Bhatt

Abstract

Hematopoietic stem cell transplantation (HSCT) is a potentially life-saving therapy that often comes at the cost of complications such as graft-versus-host disease and post-transplant infections. With improved technology to understand the ecosystem of microorganisms (viruses, bacteria, fungi, and microeukaryotes) that make up the gut microbiota, there is increasing evidence of the microbiota's contribution to the development of post-transplant complications. Antibiotics have traditionally been the mainstay of microbiota-altering therapies available to physicians. Recently, interest is increasing in the use of prebiotics and probiotics to support the development and sustainability of a healthier microbiota. In this review, we will describe the evidence for the use of prebiotics and probiotics in combating microbiota dysbiosis and explore the ways in which they may be used in future research to potentially improve clinical outcomes and decrease rates of graft-versus-host disease (GVHD) and post-transplant infection.

References

Feb 1, 1974·Journal of the National Cancer Institute·D W van BekkumD van der Waaij
Apr 1, 1984·The American Journal of Medicine·R M NavariJ D Meyers
Jan 12, 2000·Journal of Pediatric Gastroenterology and Nutrition·S GuandaliniZ Weizman
Mar 31, 2000·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·J A RussellM C Poon
Feb 6, 2003·Journal of the American College of Nutrition·Hideki IshikawaToru Otani
Feb 21, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Johannes AasJohan S Bakken
Nov 25, 2003·Digestive Diseases and Sciences·Ripudaman S BeniwalUsman A Ahmad
Apr 16, 2005·Science·Paul B EckburgDavid A Relman
May 10, 2005·The British Journal of Nutrition·Marcel B Roberfroid
May 18, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P ManzoniG Gomirato
Jun 3, 2006·Science·Steven R GillKaren E Nelson
Dec 22, 2006·Nature·Peter J TurnbaughJeffrey I Gordon
Aug 19, 2007·Proceedings of the National Academy of Sciences of the United States of America·Daniel N FrankNorman R Pace
Oct 19, 2007·Nature·Peter J TurnbaughJeffrey I Gordon
May 30, 2008·Nature·Sarkis K MazmanianDennis L Kasper
Jun 21, 2008·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·P EnckS Klosterhalfen
Oct 22, 2008·Proceedings of the National Academy of Sciences of the United States of America·Harry SokolPhilippe Langella
Nov 6, 2008·World Journal of Gastroenterology : WJG·Yue-Xin YangSophie Bourdu-Naturel
Apr 4, 2009·Nature Reviews. Immunology·June L Round, Sarkis K Mazmanian
Jun 23, 2010·Proceedings of the National Academy of Sciences of the United States of America·June L Round, Sarkis K Mazmanian
Jul 6, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Daniel WolffHildegard Greinix
Nov 3, 2010·Advances in Immunology·Janet ChowSarkis K Mazmanian
Nov 26, 2010·The New England Journal of Medicine·Ted A GooleyGeorge B McDonald
Feb 1, 2012·The American Journal of Gastroenterology·Matthew J HamiltonAlexander Khoruts

❮ Previous
Next ❯

Citations

Jul 15, 2017·Expert Review of Gastroenterology & Hepatology·Yong Seok KimKi Baik Hahm
Feb 17, 2018·Nature Reviews. Cancer·Yusuke Shono, Marcel R M van den Brink
Feb 22, 2018·Current Opinion in Clinical Nutrition and Metabolic Care·Annic BaumgartnerPhilipp Schuetz
Nov 23, 2018·Experimental Biology and Medicine·Adam D BaimDimitra Skondra
Jan 10, 2019·Current Opinion in Hematology·Shyam K PoudelLeland Metheny
Mar 11, 2018·Frontiers of Medicine·Chenyang WangJieshou Li
Oct 4, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sara Lynn Revolinski, L Silvia Munoz-Price
Jan 18, 2020·Central European Journal of Public Health·Sergio ParcoGiuseppina Palmisciano
Aug 27, 2017·American Journal of Hematology·Rory M ShallisSeah H Lim
Apr 17, 2019·Infectious Diseases and Therapy·Arhanti SadanandJeffrey J Bednarski
Dec 4, 2016·Journal of Translational Medicine·Vikram M RaghunathanSeah H Lim
Aug 14, 2020·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Andrea Z PereiraMary E Flowers
Feb 5, 2019·The Lancet Oncology·Jennifer L McQuadeJennifer A Wargo
Oct 6, 2021·Blood Advances·Riccardo MasettiAndrea Pession

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

© 2022 Meta ULC. All rights reserved